<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02727842</url>
  </required_header>
  <id_info>
    <org_study_id>CAM5657</org_study_id>
    <nct_id>NCT02727842</nct_id>
  </id_info>
  <brief_title>Usability of the CP950 Sound Processor</brief_title>
  <acronym>C950</acronym>
  <official_title>Usability of the CP950 Sound Processor With Experienced Cochlear Implant Users</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cochlear</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cochlear</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Studying usability and gaining feedback of the CP950 Sound Processor in experienced cochlear
      implant recipients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One month protocol, with 2 study visits. The aim of the study to is to gain patient and
      audiologist feedback on their experience and usability with the device and wireless
      programming pod.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2016</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient Satisfaction Through Usability of the CP950 Sound Processor as Measured by the CP950 Take Home Questionnaire</measure>
    <time_frame>1 month</time_frame>
    <description>To evaluate usability of the CP950 sound processor using the CP950 Take Home Questionnaire for existing cochlear implant users.
Specifically:
Patient Reported Hearing Performance
Retention &amp; Comfort
Ease of use
Use of remote controls
Look &amp; feel
Reliability
Maintenance &amp; use</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Hearing Loss</condition>
  <arm_group>
    <arm_group_label>Treatment group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All patients will receive the CP950 Sound Processor and be part of the treatment group for one month which is programmed via the wireless programming pod</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CP950 Sound Processor</intervention_name>
    <description>An off-the-ear processor configuration with identical functionality to the commercially approved CP910/920 processor</description>
    <arm_group_label>Treatment group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Wireless programming pod</intervention_name>
    <description>The CP950 Sound Processor will be programmed by the wireless programming pod, which is needed as the interface to commercially approved programming software</description>
    <arm_group_label>Treatment group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. At least 6 months experience with a Nucleus 24 series or later implant in at least one
             implanted ear

          2. Subjects age 12 and older who are cognitively and developmentally able to complete all
             study related questionnaires as deemed by the principal investigator or delegated
             staff

          3. At least 3 months experience with the CP810,CP920 or CP910 sound processor

          4. Ability to use 2 zinc air batteries with their current program (MAP)

          5. Willingness to participate in and to comply with all requirements of the protocol for
             the duration of the trial

        Exclusion criteria:

          1. Unrealistic expectations on the part of the subject, regarding the possible benefits,
             risks and limitations that are inherent to the procedure and prosthetic device

          2. Additional disabilities that would prevent participation in evaluations

          3. Implant types not currently supported by the CP950 sound processor (i.e.,N22)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rocky Mountain Ear Center</name>
      <address>
        <city>Englewood</city>
        <state>Colorado</state>
        <zip>80013</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NYU</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10523</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hearts for Hearing</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>March 17, 2016</study_first_submitted>
  <study_first_submitted_qc>April 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 5, 2016</study_first_posted>
  <results_first_submitted>July 16, 2018</results_first_submitted>
  <results_first_submitted_qc>August 14, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">September 12, 2018</results_first_posted>
  <last_update_submitted>August 14, 2018</last_update_submitted>
  <last_update_submitted_qc>August 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cochlear implant</keyword>
  <keyword>Sound Processor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>January 15, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/42/NCT02727842/Prot_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Treatment Group</title>
          <description>All patients will receive the CP950 Sound Processor and be part of the treatment group for one month which is programmed via the wireless programming pod
CP950 Sound Processor: An off-the-ear processor configuration with identical functionality to the commercially approved CP910/920 processor
Wireless programming pod: The CP950 Sound Processor will be programmed by the wireless programming pod, which is needed as the interface to commercially approved programming software</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Treatment Group</title>
          <description>All patients will receive the CP950 Sound Processor and be part of the treatment group for one month which is programmed via the wireless programming pod
CP950 Sound Processor: An off-the-ear processor configuration with identical functionality to the commercially approved CP910/920 processor
Wireless programming pod: The CP950 Sound Processor will be programmed by the wireless programming pod, which is needed as the interface to commercially approved programming software</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="30"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Patient Satisfaction Through Usability of the CP950 Sound Processor as Measured by the CP950 Take Home Questionnaire</title>
        <description>To evaluate usability of the CP950 sound processor using the CP950 Take Home Questionnaire for existing cochlear implant users.
Specifically:
Patient Reported Hearing Performance
Retention &amp; Comfort
Ease of use
Use of remote controls
Look &amp; feel
Reliability
Maintenance &amp; use</description>
        <time_frame>1 month</time_frame>
        <population>All enrolled subjects</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>All study participants were analyzed in the treatment group.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Satisfaction Through Usability of the CP950 Sound Processor as Measured by the CP950 Take Home Questionnaire</title>
          <description>To evaluate usability of the CP950 sound processor using the CP950 Take Home Questionnaire for existing cochlear implant users.
Specifically:
Patient Reported Hearing Performance
Retention &amp; Comfort
Ease of use
Use of remote controls
Look &amp; feel
Reliability
Maintenance &amp; use</description>
          <population>All enrolled subjects</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Satisfiaction with retention accessory</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with hearing performance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Agreed sound processor is comfortable</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Agreed sound processor is easy to use</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfied with look and feel of processor</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Agreed sound processor was reliable</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Agreed sound processor is easy to clean</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <desc>There were no unanticipated or serious adverse events reported. The All-Cause Mortality rate was zero.</desc>
      <group_list>
        <group group_id="E1">
          <title>Treatment Group</title>
          <description>There were no unanticipated or serious adverse events reported. The All-Cause Mortality rate was zero.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>3</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Mircrophone housing</sub_title>
                <description>Intermittent sound processor. The adverse event was resolved by replacing the processor. The device was subsequently analyzed and found to have dislodged microphones from the housing.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="30"/>
              </event>
              <event>
                <sub_title>Skin flap</sub_title>
                <description>Infection or swelling at implant site. August 30, 2016 was reported date of onset, and reported to the clinic on September 3, 2016. The adverse event was resolved on September 6, 2016 by antibiotic treatment.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
    </certain_agreements>
    <limitations_and_caveats>Short-term usability study, in a small population</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Kimberly Nix, Clinical Project Manager</name_or_title>
      <organization>Cochlear Americas</organization>
      <phone>303-264-2340</phone>
      <email>knix@cochlear.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

